The Chemours

CC.US

—

Markedsværdi: —Udbytteafkast: —
AdvancedEr det et godt tidspunkt at købe The Chemours? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire7. sep. 2026, 01.19

Rezubio Announces FDA and NMPA IND Clearances and First Cohort Dosing of RZ-520, a Novel Inhaled Therapy for Chronic Respiratory Diseases

AFP7. sep. 2026, 01.17

25 years on, America seeks to keep 9/11 memories alive

AFP7. sep. 2026, 01.16

AI data centers are less thirsty now, tech giants say